Orgenesis Inc
NASDAQ:ORGS 11:26:39 AM EDT
| Market Cap (Intraday) | 18.24M |
| Current PE | N/A |
| Forward PE | 3 |
| 2yr Forward PE | 1.03 |
| 10-Day MA | $0.66 |
| 50-Day MA | $0.87 |
| 200-Day MA | $1.40 |
Orgenesis Inc Stock, NASDAQ:ORGS
20271 Goldenrod Lane, 20271 Goldenrod Lane, Germantown, Maryland 20876
United States of America
Phone: +1.480.659.6404
Number of Employees: 167
Description
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.